ATRC

NASDAQ HEALTHCARE

AtriCure Inc

$56.37

$1.23 (+2.23%)

Live quote

52w: $25.36 – $61.70

Loading chart…

P/E Ratio—

P/B Ratio5.43

EV/EBITDA—

Debt/Equity—

ROE-2.22%

ROIC—

Revenue Growth14.88%

Gross Margin74.98%

AtriCure, Inc. develops, manufactures, and sells devices for the surgical ablation of cardiac tissue and systems to medical centers in the United States, Europe, Asia, and internationally. The company is headquartered in Mason, Ohio.

Own ATRC? Track it here.

Create a free account to add ATRC to a portfolio and watch your P/L update in real time.

Custom screens, valuation models and backtesting are coming to Pro.

Create a free account